United States · Who invested in Neuraly?
Neuraly's investors include Smilegate Investment, LB Investment, InterVest, Magna and D&D Pharmatech/ Smilegate, and 2 more on record.
United States · Series A startup
Who invested in Neuraly
Funding summaryUpdated 26 Oct 2026
$36Mraised across 1 round since 2018, from 1 source
- Latest round
- Series A, $36MJul 2018
- Investors
- 7
The rounds
- Jul 2018Series A$36M
Smilegate Investment
LB Investment- InterVest
Magna- D&D Pharmatech/ Smilegate
- Dongkoo Bio&Pharma
- Geon
Reported by VcnewsdailySEC filing: $10M sold, first sale Apr 2018
Founders and team
From Neuraly's own website: 3 on the team.
- Eling WongDirector, Clinical Operations
- Sangho KimAccounting Manager
- Taylor LeeR&D Program Manager
Everyone who backed them
InterVestCorporate VC1round
D&D Pharmatech/ Smilegateno record of our own yet1round
Dongkoo Bio&Pharmano record of our own yet1round
Geonno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Neuraly
How much has Neuraly raised?
Neuraly has raised $36M across 1 round since 2018.
When did Neuraly last raise?
Neuraly's most recent round was a Series A of $36M in Jul 2018.
What was Neuraly's biggest round?
Its most recent round, $36M in Jul 2018, is also its largest on record.
Who backed Neuraly first?
Neuraly's first round on record, in Jul 2018, was backed by Smilegate Investment, LB Investment and InterVest and 4 others.
What stage is Neuraly at?
Neuraly's latest named round is a Series A, in Jul 2018.
Where is Neuraly based?
Neuraly is based in the United States.
Companies like Neuraly
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.